ONS/ONCC CHEMOTHERAPY IMMUNOTHERAPY
CERTIFICATION | FUNDAMENTALS EXAM 2024
QUESTIONS AND ANSWERS ALREADYGRADED A |
LATEST UPDATE
A patient reports pain unrelieved by oxycodone. The initial for the nurse is to:
A. Request an order for additional medication
B. Consult with palliative care services
C. Report it to the prescribing physician
D. Assess the discomfort in 30 minutes
C. Report it to the prescribing physician
A patient is scheduled to receive melphalan 140 mg/m2. The patient's measurements are
as follows: height 173 cm and weight 85 kg. Using the Mosteller formula, what is the dose
to be administered?
A. 257 mg
B. 283 mg
C. 295 mg
D. 280 mg
B. 283 mg
Which of the following is an example of a passive immunotherapy agent?
A. Trastuzumab*
B. Sipuleucel-T
C. Melphalan
D. Cladribine
A. Trastuzumab
Which of the following is a characteristic of a cancer cell.
A. Restricted movement
, ONS/ONCC CHEMOTHERAPY IMMUNOTHERAPY
CERTIFICATION | FUNDAMENTALS EXAM 2024
QUESTIONS AND ANSWERS ALREADYGRADED A |
LATEST UPDATE
B. Orderly arrangement
C. Uncontrolled division
D. Sustained apoptosis
C. Uncontrolled division
What is the common term for cytokine release syndrome?
A. Angiogenic event
B. Cell signaling
C. Infusion reaction
D. Cell apoptosis
C. Infusion reaction
Which statement made by a patient ordered high dose melphalan shows an understanding of
the provided teaching?
A. "I should avoid sun exposure."
B. "I know that this medication causes constipation."
C. "I should empty my bladder frequently."
D. I should suck on ice during administration."*
D. I should suck on ice during administration."*
Which of the following hormonal agents is classified as an aromatase inhibitor?
A. Flutamide
B. Leuprolide
C. Tamoxifen
D. Exemestane*
D. Exemestane*
A patient scheduled for a second dose of flourouracil reports reddening of the skin on the
arms, face and neck after gardening. The nurses best response is to:
A. Encourage the use of sunscreen when outside
B. Withhold the chemotherapy and call the oncologist*
, ONS/ONCC CHEMOTHERAPY IMMUNOTHERAPY
CERTIFICATION | FUNDAMENTALS EXAM 2024
QUESTIONS AND ANSWERS ALREADYGRADED A |
LATEST UPDATE
C. Instruct on taking cool showers and baths
D. Reassure that these symptoms are expected
A. Encourage the use of sunscreen when outside
A patient who completed a third cycle of trastuzumab, doxorubicin, cyclophosphamide, and
paclitaxel reports numbness and tingling of hands and feet. Which medication is most likely
the cause of this side effect?
A. Cyclophosphamide
B. Trastuzumab
C. Paclitaxel*
D. Doxorubicin
C. Paclitaxel*
To help prevent dose-limiting myelosuppression, give paclitaxel before:
A. Antitumor antibodies
B. Antimetabolites
C. Alkylating agents*
D. Vinca Alkaloids
C. Alkylating agents*
Which of the following medications is a non-anthracycline antitumor antibiotic?
A. Daunorubicin
B. Idarubicin
C. Mitomycin-C
D. Epirubicin
C. Mitomycin-C
A patient with acute myeloid leukemia begins induction therapy that consists of daily
daunorubicin for three days and continuous cytarabine for seven days. On day two,
midostaurin is prescribed. What likely precipitated this new order?
A. A final cytology report was positive for FLT3 mutation*
B. The patient has developed a secondary malignancy.
, ONS/ONCC CHEMOTHERAPY IMMUNOTHERAPY
CERTIFICATION | FUNDAMENTALS EXAM 2024
QUESTIONS AND ANSWERS ALREADYGRADED A |
LATEST UPDATE
C. The patient missed the second dose of daunorubicin.
D. The blast percentage remains high on a peripheral smear.
A. A final cytology report was positive for FLT3 mutation*
A monoclonal antibody that targets angiogenesis is ordered for a patient with lung cancer. The
patient is most likely being treated with:
A. Vandetanib
B. Bevacizumab*
C. Cetuximab
D. pazopanib
B. Bevacizumab
Which agent potentiates cardiotoxicity when administered with trastuzumab?
A. Daunorubicin*
B. Gemcitabine
C. Carmustine
D. Bleomycin
A. Daunorubicin
Fulvestrant dosing
includes
A. a 20 mg tablet once per day
B. two intramuscular injections every four weeks.*
C. A subcutaneous injection every four weeks.
D. a 400 mg tablet three times a day
B. two intramuscular injections every four weeks.*
Which statement best describes the mechanism of action of targeted anticancer therapy?
A. Block cancer cell proliferation causing cytotoxicity of cancer cells.*
B. Act on rapidly dividing cells, which causes an increase in cell death.
C. Interfere with specific pathways on or within the cancer cell.
D. Selectively target DNA and cell division mechanisms.
C. Interfere with specific pathways on or within the cancer cell.
CERTIFICATION | FUNDAMENTALS EXAM 2024
QUESTIONS AND ANSWERS ALREADYGRADED A |
LATEST UPDATE
A patient reports pain unrelieved by oxycodone. The initial for the nurse is to:
A. Request an order for additional medication
B. Consult with palliative care services
C. Report it to the prescribing physician
D. Assess the discomfort in 30 minutes
C. Report it to the prescribing physician
A patient is scheduled to receive melphalan 140 mg/m2. The patient's measurements are
as follows: height 173 cm and weight 85 kg. Using the Mosteller formula, what is the dose
to be administered?
A. 257 mg
B. 283 mg
C. 295 mg
D. 280 mg
B. 283 mg
Which of the following is an example of a passive immunotherapy agent?
A. Trastuzumab*
B. Sipuleucel-T
C. Melphalan
D. Cladribine
A. Trastuzumab
Which of the following is a characteristic of a cancer cell.
A. Restricted movement
, ONS/ONCC CHEMOTHERAPY IMMUNOTHERAPY
CERTIFICATION | FUNDAMENTALS EXAM 2024
QUESTIONS AND ANSWERS ALREADYGRADED A |
LATEST UPDATE
B. Orderly arrangement
C. Uncontrolled division
D. Sustained apoptosis
C. Uncontrolled division
What is the common term for cytokine release syndrome?
A. Angiogenic event
B. Cell signaling
C. Infusion reaction
D. Cell apoptosis
C. Infusion reaction
Which statement made by a patient ordered high dose melphalan shows an understanding of
the provided teaching?
A. "I should avoid sun exposure."
B. "I know that this medication causes constipation."
C. "I should empty my bladder frequently."
D. I should suck on ice during administration."*
D. I should suck on ice during administration."*
Which of the following hormonal agents is classified as an aromatase inhibitor?
A. Flutamide
B. Leuprolide
C. Tamoxifen
D. Exemestane*
D. Exemestane*
A patient scheduled for a second dose of flourouracil reports reddening of the skin on the
arms, face and neck after gardening. The nurses best response is to:
A. Encourage the use of sunscreen when outside
B. Withhold the chemotherapy and call the oncologist*
, ONS/ONCC CHEMOTHERAPY IMMUNOTHERAPY
CERTIFICATION | FUNDAMENTALS EXAM 2024
QUESTIONS AND ANSWERS ALREADYGRADED A |
LATEST UPDATE
C. Instruct on taking cool showers and baths
D. Reassure that these symptoms are expected
A. Encourage the use of sunscreen when outside
A patient who completed a third cycle of trastuzumab, doxorubicin, cyclophosphamide, and
paclitaxel reports numbness and tingling of hands and feet. Which medication is most likely
the cause of this side effect?
A. Cyclophosphamide
B. Trastuzumab
C. Paclitaxel*
D. Doxorubicin
C. Paclitaxel*
To help prevent dose-limiting myelosuppression, give paclitaxel before:
A. Antitumor antibodies
B. Antimetabolites
C. Alkylating agents*
D. Vinca Alkaloids
C. Alkylating agents*
Which of the following medications is a non-anthracycline antitumor antibiotic?
A. Daunorubicin
B. Idarubicin
C. Mitomycin-C
D. Epirubicin
C. Mitomycin-C
A patient with acute myeloid leukemia begins induction therapy that consists of daily
daunorubicin for three days and continuous cytarabine for seven days. On day two,
midostaurin is prescribed. What likely precipitated this new order?
A. A final cytology report was positive for FLT3 mutation*
B. The patient has developed a secondary malignancy.
, ONS/ONCC CHEMOTHERAPY IMMUNOTHERAPY
CERTIFICATION | FUNDAMENTALS EXAM 2024
QUESTIONS AND ANSWERS ALREADYGRADED A |
LATEST UPDATE
C. The patient missed the second dose of daunorubicin.
D. The blast percentage remains high on a peripheral smear.
A. A final cytology report was positive for FLT3 mutation*
A monoclonal antibody that targets angiogenesis is ordered for a patient with lung cancer. The
patient is most likely being treated with:
A. Vandetanib
B. Bevacizumab*
C. Cetuximab
D. pazopanib
B. Bevacizumab
Which agent potentiates cardiotoxicity when administered with trastuzumab?
A. Daunorubicin*
B. Gemcitabine
C. Carmustine
D. Bleomycin
A. Daunorubicin
Fulvestrant dosing
includes
A. a 20 mg tablet once per day
B. two intramuscular injections every four weeks.*
C. A subcutaneous injection every four weeks.
D. a 400 mg tablet three times a day
B. two intramuscular injections every four weeks.*
Which statement best describes the mechanism of action of targeted anticancer therapy?
A. Block cancer cell proliferation causing cytotoxicity of cancer cells.*
B. Act on rapidly dividing cells, which causes an increase in cell death.
C. Interfere with specific pathways on or within the cancer cell.
D. Selectively target DNA and cell division mechanisms.
C. Interfere with specific pathways on or within the cancer cell.
